155 related articles for article (PubMed ID: 26122663)
1. Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells.
Kang DW; Choi CY; Cho YH; Tian H; Di Paolo G; Choi KY; Min do S
J Exp Med; 2015 Jul; 212(8):1219-37. PubMed ID: 26122663
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
Kang DW; Lee SW; Hwang WC; Lee BH; Choi YS; Suh YA; Choi KY; Min DS
Cancer Res; 2017 Jan; 77(1):142-152. PubMed ID: 27793841
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
4. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
5. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
Xu H; Li J; Chen H; Ghishan FK
Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
[TBL] [Abstract][Full Text] [Related]
6. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
7. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
8. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
[TBL] [Abstract][Full Text] [Related]
9. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling.
Arimura S; Matsunaga A; Kitamura T; Aoki K; Aoki M; Taketo MM
Gastroenterology; 2009 Aug; 137(2):629-38. PubMed ID: 19427313
[TBL] [Abstract][Full Text] [Related]
10. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
[TBL] [Abstract][Full Text] [Related]
11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth.
Zheng W; Wong KE; Zhang Z; Dougherty U; Mustafi R; Kong J; Deb DK; Zheng H; Bissonnette M; Li YC
Int J Cancer; 2012 Jan; 130(1):10-9. PubMed ID: 21328347
[TBL] [Abstract][Full Text] [Related]
13. Nuclear partitioning of Prohibitin 1 inhibits Wnt/β-catenin-dependent intestinal tumorigenesis.
Alula KM; Delgado-Deida Y; Jackson DN; Venuprasad K; Theiss AL
Oncogene; 2021 Jan; 40(2):369-383. PubMed ID: 33144683
[TBL] [Abstract][Full Text] [Related]
14. PAK1 promotes intestinal tumor initiation.
Dammann K; Khare V; Harpain F; Lang M; Kurtovic A; Mesteri I; Evstatiev R; Gasche C
Cancer Prev Res (Phila); 2015 Nov; 8(11):1093-101. PubMed ID: 26304465
[TBL] [Abstract][Full Text] [Related]
15. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
16. Voluntary exercise inhibits intestinal tumorigenesis in Apc(Min/+) mice and azoxymethane/dextran sulfate sodium-treated mice.
Ju J; Nolan B; Cheh M; Bose M; Lin Y; Wagner GC; Yang CS
BMC Cancer; 2008 Nov; 8():316. PubMed ID: 18976499
[TBL] [Abstract][Full Text] [Related]
17. Adamts18 deficiency promotes colon carcinogenesis by enhancing β-catenin and p38MAPK/ERK1/2 signaling in the mouse model of AOM/DSS-induced colitis-associated colorectal cancer.
Lu T; Dang S; Zhu R; Wang Y; Nie Z; Hong T; Zhang W
Oncotarget; 2017 Mar; 8(12):18979-18990. PubMed ID: 28145888
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferation.
Jeppsson S; Srinivasan S; Chandrasekharan B
Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G103-G111. PubMed ID: 27856419
[TBL] [Abstract][Full Text] [Related]
19. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer.
Velázquez KT; Enos RT; McClellan JL; Cranford TL; Chatzistamou I; Singh UP; Nagarkatti M; Nagarkatti PS; Fan D; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G347-58. PubMed ID: 26744471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
